On November 13, 2025, according to sources cited by Reuters, Wu Qing, the chairman of the China Securities Regulatory Commission, has reportedly applied to resign citing health reasons, although related institutions have not responded to this rumor. However, on the same night, the China Securities Regulatory Commission issued a press release stating that Wu Qing visited France and Brazil from November 10 to 13.
It is reported that Wu Qing has expressed his resignation intention to the relevant departments. It is currently unclear whether his resignation has been approved and when he will step down. Due to the sensitive nature of the situation, the sources refused to disclose their names.
Reuters stated that this personnel change came somewhat suddenly and unexpectedly.
Wu Qing, the China Securities Regulatory Commission, and the State Council Information Office of the People’s Republic of China have not immediately responded to Reuters’ request for comment.
However, on the evening of November 13, the official website of the Securities Regulatory Commission released a statement saying that from November 10 to 13, Wu Qing visited Paris, France, and Rio de Janeiro, Brazil, and held bilateral meetings with Marie-Anne Barbat-Layani, chairman of the French Financial Markets Authority (AMF), and Mr. Otto Lobo, acting chairman of the Brazilian Securities and Exchange Commission (CVM), and Ms. Marina Copola, a commissioner.
Topics regarding Wu Qing surged on Weibo on November 13, and it caught the attention of reporters at Epoch Times. The topic briefly ranked fourth, but within less than 30 minutes, it completely disappeared from the trending list.
Many financial bloggers expressed their views, with one saying, “I am also waiting for news media on why this topic emerged.” Another mentioned, “Sending a strong signal!” and “Resignation due to rumor pressure.”
However, a prominent financial figure on social platform X posted, “Rumor: liver cancer, he has had it for a while now, the Agricultural Bank Chairman to be his successor.” They added, “He underwent two surgeries before joining the Securities Regulatory Commission (one for colon cancer).” “While serving as deputy mayor, he had liver cancer surgery and had a part of his liver removed.”
On February 7, 2024, Wu Qing succeeded the dismissed Yi Huiman as the chairman of the China Securities Regulatory Commission and continued to strengthen stock market regulation, increase the force to delist non-performing stocks, and tighten the rules for new stock listings.
Public records show that Wu Qing was born in April 1965 in Mengcheng, Anhui Province, and holds a Ph.D. in Economics. He has held various positions such as Director at the Comprehensive Department of the National Development and Reform Commission, cadre at the Office of the Securities Commission of the State Council, Deputy Director of the Organizational Department of the China Securities Regulatory Commission (at the department level), Director of the Organizational Supervision Department, Director of the Securities Company Risk Disposal Office, and Director of the Fund Supervision Department.
In 2010, Wu Qing served as Deputy Secretary, District Head, and District Secretary of the Hongkou District Committee in Shanghai, Chairman of the Board and Party Secretary of the Shanghai Stock Exchange Council, and Vice Mayor of Shanghai, among other positions.
Starting from 2019, Wu Qing was a member of the Standing Committee and Vice Mayor of the Shanghai Municipal Committee. In July 2023, he became Deputy Secretary of the Shanghai Municipal Committee. In August, Wu Qing participated in activities as Deputy Secretary of the Shanghai Municipal Committee and Secretary of the Political and Legal Committee. In February 2024, he became Party Secretary and Chairman of the China Securities Regulatory Commission.
During his tenure as the Director of the Risk Disposal Office for securities companies in 2005, Wu Qing was tasked with handling 31 problematic securities firms including Southern Securities and Minfa Securities, leading 26 of them into bankruptcy proceedings. He was known in the industry as the “Terminator of Problematic Securities Firms” and the “Butcher of Securities Firms.”